This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin
Study Type
OBSERVATIONAL
Enrollment
800
Patients undergo liver resection for tumor.
Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
RECRUITINGoverall survival
Time frame: From date of treatment until the date of death from any cause, assessed up to 100 months
Incidence of Adverse Events
Time frame: Within 30 days following interventions
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.